Specific impact of past and new major cardiovascular events on acute kidney injury and end-stage renal disease risks in diabetes: a dynamic view.

cardiovascular events diabetes mellitus end-stage renal disease epidemiology heart failure

Journal

Clinical kidney journal
ISSN: 2048-8505
Titre abrégé: Clin Kidney J
Pays: England
ID NLM: 101579321

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 05 07 2018
accepted: 21 02 2019
entrez: 22 2 2020
pubmed: 23 2 2020
medline: 23 2 2020
Statut: epublish

Résumé

Interconnections between major cardiovascular events (MCVEs) and renal events are recognized in diabetes, however, the specific impact of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS) on the risk of end-stage renal disease (ESRD) on top of established renal risk factors is unclear in type 2 diabetes mellitus. We conducted a retrospective study in 861 consecutive patients followed in a nephrology setting during the 2000-13 period. The mean age was 70 ± 10 years, 65.1% were men and the estimated glomerular filtration rate (eGFR) was 42.4 ± 21.0 mL/min/1.73 m Past and new cardiovascular events (more HF and AF than ACS) have a strong, independent impact on the development of ESRD above and beyond established risk factors in diabetes.

Sections du résumé

BACKGROUND BACKGROUND
Interconnections between major cardiovascular events (MCVEs) and renal events are recognized in diabetes, however, the specific impact of atrial fibrillation (AF), heart failure (HF) and acute coronary syndrome (ACS) on the risk of end-stage renal disease (ESRD) on top of established renal risk factors is unclear in type 2 diabetes mellitus.
METHODS METHODS
We conducted a retrospective study in 861 consecutive patients followed in a nephrology setting during the 2000-13 period.
RESULTS RESULTS
The mean age was 70 ± 10 years, 65.1% were men and the estimated glomerular filtration rate (eGFR) was 42.4 ± 21.0 mL/min/1.73 m
CONCLUSIONS CONCLUSIONS
Past and new cardiovascular events (more HF and AF than ACS) have a strong, independent impact on the development of ESRD above and beyond established risk factors in diabetes.

Identifiants

pubmed: 32083616
doi: 10.1093/ckj/sfz028
pii: sfz028
pmc: PMC7025370
doi:

Types de publication

Journal Article

Langues

eng

Pagination

17-23

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.

Références

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1189-96
pubmed: 27073197
Diabetes Res Clin Pract. 2014 Feb;103(2):137-49
pubmed: 24630390
Stroke. 2015 Nov;46(11):3226-31
pubmed: 26486869
Clin J Am Soc Nephrol. 2009 Mar;4(3):616-22
pubmed: 19211666
J Am Coll Cardiol. 2004 Jan 7;43(1):61-7
pubmed: 14715185
Clin J Am Soc Nephrol. 2011 Nov;6(11):2567-72
pubmed: 21903988
Kidney Int. 2004 Sep;66(3):1173-9
pubmed: 15327414
Heart Fail Rev. 2012 Mar;17(2):177-90
pubmed: 21688186
Kidney Int. 2011 Jul;80(1):93-104
pubmed: 21289597
Heart. 2015 Nov;101(22):1778-85
pubmed: 26243789
Nat Rev Nephrol. 2009 Nov;5(11):641-9
pubmed: 19786991
Diabetes Care. 2015 Dec;38(12):2333-40
pubmed: 26512039
J Am Soc Nephrol. 2009 Jan;20(1):223-8
pubmed: 19020007
Nephrol Dial Transplant. 2012 Oct;27(10):3885-91
pubmed: 23114906
QJM. 2005 Feb;98(2):119-26
pubmed: 15655096
BMC Nephrol. 2016 Sep 21;17(1):135
pubmed: 27655374
Heart Rhythm. 2010 Apr;7(4):438-44
pubmed: 20153266
Lancet Diabetes Endocrinol. 2014 Jan;2(1):56-64
pubmed: 24622669
J Am Soc Nephrol. 2016 Nov;27(11):3488-3497
pubmed: 27151925
Kidney Int. 2008 Aug;74(3):356-63
pubmed: 18496515
Crit Care. 2013 Feb 04;17(1):204
pubmed: 23394211
Intensive Care Med. 2008 May;34(5):957-62
pubmed: 18251008
Am J Kidney Dis. 2014 Jul;64(1):74-85
pubmed: 24787763
J Am Coll Cardiol. 2017 Nov 28;70(21):2621-2632
pubmed: 29169468
J Card Fail. 2007 Oct;13(8):599-608
pubmed: 17923350
Ann Intern Med. 2003 Jul 15;139(2):137-47
pubmed: 12859163
J Am Soc Nephrol. 2013 Mar;24(4):529-36
pubmed: 23349311
Diabetes Res Clin Pract. 2010 Sep;89(3):201-8
pubmed: 20599286
Nephrol Dial Transplant. 2009 Jan;24(1):194-200
pubmed: 18728156
Circulation. 2018 Aug 28;138(9):929-944
pubmed: 30354446
Clin J Am Soc Nephrol. 2014 Mar;9(3):448-56
pubmed: 24311708

Auteurs

Cédric Pinier (C)

Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.

Philippe Gatault (P)

Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.
EA4245, François-Rabelais University, Tours, France.

Laurent Fauchier (L)

Service de Cardiologie, Hôpital Trousseau, CHU Tours, Tours, France.

Denis Angoulvant (D)

EA4245, François-Rabelais University, Tours, France.
Service de Cardiologie, Hôpital Trousseau, CHU Tours, Tours, France.

Maud François (M)

Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.

Christelle Barbet (C)

Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.

Elodie Bailly (E)

Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.

Johan Noble (J)

Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.

Eloi Chevallier (E)

Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.

Nolwenn Rabot (N)

Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.

Matthias Büchler (M)

Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.
EA4245, François-Rabelais University, Tours, France.

Bénédicte Sautenet (B)

Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.
Inserm U1246, François-Rabelais University, Tours, France.
FCRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, France.

Jean-Michel Halimi (JM)

Service de Néphrologie-Hypertension, Dialyses, Transplantation Rénale, Hôpital Bretonneau, CHU Tours, Tours, France.
EA4245, François-Rabelais University, Tours, France.
FCRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, France.

Classifications MeSH